Publications
Publications
Show Results For
- All HBS Web
(1,466)
- Faculty Publications (396)
COVID-19
→
- 2020
- Working Paper
How Should U.S. Bank Regulators Respond to the COVID-19 Crisis?
By: Michael Blank, Samuel G. Hanson, Jeremy C. Stein and Adi Sunderam
Drawing on lessons from the 2007–2009 Global Financial Crisis (GFC) and a simple conceptual framework, we examine the response of U.S. bank regulators to the COVID-19 pandemic. We argue that the current regulatory strategy of “watchful waiting”—the same strategy that... View Details
- 2020
- Guest Column
Learning from Lehman: Lessons for Today
By: Laura Comstock, Michael Holland and Peter Tufano
- May 27, 2020
- Editorial
Stable Democracies Better at Fostering Economic Growth
By: Ashish Nanda
Differences across countries in how the COVID-19 pandemic has been managed have led some to raise the broader question of whether democracies are necessarily a good way to organise a society. Research findings clearly show that compared to autocracies, democracies... View Details
- Article
The Business of Medicine in the Era of COVID-19
By: David M. Cutler, Sayeh Nikpay and Robert S. Huckman
This Viewpoint discusses the shifting landscape of health care financing, regulation, and delivery as a result of the coronavirus pandemic, and discusses regulatory and other changes that need to be in place if telehealth and physician practice and hospital mergers... View Details
- May 21, 2020
- Editorial
Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?
By: Leemore S. Dafny and J. Michael McWilliams
Primary care clinicians are the front line for patients with suspected infection. We rely on them to diagnose, triage, and manage patients with potential or confirmed COVID infections. They are also responsible for keeping non-COVID medical conditions under control... View Details
- May 2020 (Revised March 2022)
- Case
The Coronavirus (COVID-19) Pandemic and the Global Economy (A)
By: Alberto Cavallo and Christian Godwin
In April 2020, the world struggled to contain the exponential escalation of the coronavirus (COVID-19) pandemic. Dozens of countries had imposed restrictions on travel, work, and social gatherings. A large share of the global population was under lockdowns and... View Details
Keywords: COVID-19 Pandemic; Demand and Consumers; Supply and Industry; Finance; Central Banking; Financial Markets; International Finance; Globalization; Government and Politics; Health Pandemics; Decision Making; Macroeconomics; Employment; Crisis Management; Supply Chain; Risk and Uncertainty; Air Transportation Industry; Banking Industry; Consumer Products Industry; Employment Industry; Financial Services Industry; Food and Beverage Industry; Health Industry; Medical Devices and Supplies Industry; Pharmaceutical Industry; Public Administration Industry; Retail Industry; Service Industry; Shipping Industry; Tourism Industry; Travel Industry; Asia; China; Europe; Latin America; Africa; United States
- Article
How to End the Plasma Shortage for Coronavirus Patients
Those who have recovered from the virus will donate more blood if given the right incentives. View Details
- May 8, 2020
- Article
Lead Your Team Into a Post-Pandemic World
By: Hubert Joly
The unprecedented COVID-19 pandemic has tested leaders, especially as it relates to how they lead their workers. As the crisis goes on, many that the author has spoken with have begun to frame it around three distinct phases: The Shelter-in-Place Phase, the Re-opening... View Details
- May 8, 2020
- Article
Which Covid-19 Data Can You Trust?
By: Satchit Balsari, Caroline Buckee and Tarun Khanna
The COVID-19 pandemic has produced a tidal wave of data, but how much of it is any good? And as a layperson, how can you sort the good from the bad? The authors suggest a few strategies for dividing the useful data from the misleading: Beware of data that’s too broad... View Details
- 2020
- Working Paper
Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design
By: Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez and M. Utku Ünver
COVID-19 convalescent plasma (CCP) therapy is currently a leading treatment for COVID-19. At present, there is a shortage of CCP relative to demand. We develop and analyze a model of centralized CCP allocation that incorporates both donation and distribution. In order... View Details
- May 6, 2020
- Article
We Shouldn't Wait for a Breakthrough in the COVID-19 Pandemic
By: Gary P. Pisano
The ultimate solutions to the COVID-19 crisis may be big breakthroughs in building massive test and trace capacity and developing vaccines and drug remedies. But in the meantime, we should not ignore the potential cumulative impact of the many small things we already... View Details
- 2020
- Working Paper
Food Security and Human Mobility During the COVID-19 Lockdown
By: Prithwiraj Choudhury, Wesley W. Koo, Xina Li, Nishant Kishore, Satchit Balsari and Tarun Khanna
During the COVID-19 crisis, millions of migrants around the world face food insecurity. This could force migrants to travel during the pandemic, exposing them to health risks and accelerating the spread of the virus. Anecdotal evidence demonstrates the importance of... View Details
Keywords: COVID-19; Migrants; Food Security; Mobility; Health Pandemics; Food; Distribution; Policy; Global Range
- May 2020 (Revised April 2024)
- Case
Gavi and COVID-19: Pandemic of the Century
By: Tarun Khanna and Sid Misra
Gavi has helped immunize over 760 million children in the world's poorest countries over the past 20 years saving 13 million lives. How should Gavi respond to the need for a vaccine for the worldwide COVID-19 pandemic? View Details
- May 1, 2020
- Article
COVID-19's Hard Lessons Might Prepare Business for Climate Change
By: Joseph B. Lassiter III and Danielle Kost
The coronavirus pandemic caught the business world by surprise, but the catastrophe might force companies to face a crisis that has been unfolding in plain sight: climate change.
We asked faculty members affiliated with the Business and Environment Initiative at... View Details
We asked faculty members affiliated with the Business and Environment Initiative at... View Details
- April 29, 2020
- Article
How Should We Allocate Scarce Medical Resources?
By: Max Bazerman, Regan Bernhard, Joshua D. Greene, Karen Huang and Netta Barak-Corren
Who should get a ventilator if there aren’t enough to go around? Research on decision making leads to three concrete guidelines that policy-makers and physicians can use to make fair choices when allocating scarce, life-saving resources. The key to making fair and... View Details
Keywords: COVID-19; Health Pandemics; Resource Allocation; Decision Making; Policy; Fairness; Ethics
- April 24, 2020
- Article
Lessons from the NFL: Virtual Hiring, Leadership, Building Teams and COVID-19
By: Sarah Abbott, Boris Groysberg, Tali Groysberg and Abhijit Naik
- 2020
- Working Paper
HBS COVID-19 Global Policy Tracker
By: Alberto Cavallo and Tannya Cai
The HBS COVID-19 Global Policy Tracker is an initiative by the Business, Government and the International Economy (BGIE) unit at Harvard Business School (HBS) to collect and standardize economic policies implemented as a response to the coronavirus pandemic around the... View Details
- April 23, 2020
- Other Article
The Impact of Covid-19 on Psychological Safety in the Workplace (Interview)
By: Amy C. Edmondson
Keywords: Psychological Safety
- April 15, 2020
- Other Article
Designating Certain Post-Acute Care Facilities As COVID-19 Skilled Care Centers Can Increase Hospital Capacity And Keep Nursing Home Patients Safer
By: Leemore S. Dafny and Steven S. Lee
As the number of COVID-19 cases nationwide continues to grow, many hospitals will need to convert acute care beds into intensive care beds and discharge stable patients to post-acute care settings such as nursing homes. In addition, nursing homes unable to care for... View Details
- April 13, 2020
- Article